Core Insights - Wall Street analysts anticipate Privia Health (PRVA) will report quarterly earnings of $0.06 per share, reflecting a year-over-year increase of 200% [1] - Expected revenues for the quarter are $417.6 million, which represents a decline of 5.3% compared to the same quarter last year [1] - The consensus EPS estimate has remained stable over the past 30 days, indicating a reevaluation of initial estimates by analysts [1] Earnings Estimates and Market Reactions - Changes in earnings estimates are critical for predicting investor reactions to stock performance [2] - Empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [2] Key Metrics Projections - Analysts project 'Practice Collections' to reach $719.81 million, down from $756.60 million reported in the same quarter last year [4] - The estimated 'Care Margin' is $101.70 million, an increase from $91.45 million in the previous year [4] - The consensus for 'Platform Contribution' is expected to be $48.89 million, up from $42.28 million reported in the same quarter last year [5] Stock Performance - Privia Health shares have increased by 7.2% over the past month, contrasting with a -1.8% change in the Zacks S&P 500 composite [5] - With a Zacks Rank of 3 (Hold), PRVA is expected to perform in line with the overall market in the near future [5]

Core Viewpoint - Privia Health Group, Inc. is set to announce its financial results for the fourth quarter and full-year periods ending December 31, 2024, on February 27, 2025, before market open [1]. Financial Results Announcement - The financial results press release will be publicly available by 7:00 am ET on February 27, 2025, and can be accessed on the company's Investor Relations website [2]. - A conference call will be hosted by Privia Health management at 8:00 am ET on the same day to discuss the financial results and future outlook [2][3]. Conference Call Details - The conference call can be accessed via live webcast, with an archived version available for on-demand listening shortly after the call [3]. - To participate in the live call, interested parties can dial 646-968-2525 or 888-596-4144 for international callers, using Conference ID 5704885 [3]. Company Overview - Privia Health is a technology-driven national physician enablement company that collaborates with medical groups, health plans, and health systems to enhance physician practices and patient experiences [4]. - The Privia Platform is characterized by scalable operations and cloud-based technology aimed at reducing healthcare costs and improving patient outcomes [4].

Core Insights - Definitive Healthcare Corp. (DH) and Privia Health (PRVA) are being compared for their value opportunities, with DH currently rated 2 (Buy) and PRVA rated 3 (Hold) according to the Zacks Rank [2][4] - DH has a forward P/E ratio of 12.07, significantly lower than PRVA's forward P/E of 137.64, indicating a more attractive valuation for DH [3] - DH's PEG ratio is 1.32, while PRVA's PEG ratio is 5.23, suggesting that DH is expected to grow earnings at a more favorable rate relative to its price [3] - DH has a P/B ratio of 0.70 compared to PRVA's P/B of 3.63, further supporting the argument that DH is undervalued [6] - Based on these valuation metrics, DH has earned a Value grade of A, while PRVA has a Value grade of C, indicating that DH is the superior value option at this time [6] Valuation Metrics - The forward P/E ratio for DH is 12.07, while PRVA's is 137.64, highlighting a significant difference in valuation [3] - The PEG ratio for DH is 1.32, compared to PRVA's 5.23, indicating a more favorable growth outlook for DH [3] - DH's P/B ratio stands at 0.70, while PRVA's is 3.63, suggesting that DH is trading at a lower valuation relative to its book value [6] Investment Outlook - The Zacks Rank emphasizes companies with positive earnings estimate revisions, which is a favorable indicator for DH's earnings outlook [2] - Value investors typically consider various fundamental metrics, including P/E, P/S, earnings yield, and cash flow per share, to identify undervalued stocks [5] - The analysis suggests that DH presents a better value opportunity compared to PRVA based on the current financial metrics [6]

Core Insights - Definitive Healthcare Corp. (DH) and Privia Health (PRVA) are being compared for value investment opportunities, with DH currently showing stronger potential for value investors [1][3]. Valuation Metrics - DH has a forward P/E ratio of 13.79, significantly lower than PRVA's forward P/E of 148.10, indicating that DH may be undervalued [5]. - The PEG ratio for DH is 1.51, while PRVA's PEG ratio is 5.63, suggesting that DH has a more favorable growth outlook relative to its valuation [5]. - DH's P/B ratio stands at 0.79, compared to PRVA's P/B of 3.91, further indicating that DH is more attractively priced relative to its book value [6]. Investment Grades - DH holds a Value grade of A, while PRVA has a Value grade of C, reflecting DH's superior valuation metrics and earnings outlook [7].

PRIVI 1 3 rd Quarter 2024 Results November 7, 2024 Parth Mehrotra – Chief Executive Officer David Mountcastle – Chief Financial Officer Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to: 2024 financial guidance and other projections and forecasts. These forward-looking statements invo ...

Core Insights - Privia Health reported revenue of $437.92 million for the quarter ended September 2024, reflecting a 5% increase year-over-year and a surprise of +5.67% over the Zacks Consensus Estimate of $414.44 million [1] - The company's EPS was $0.03, down from $0.05 in the same quarter last year, resulting in an EPS surprise of -50.00% compared to the consensus estimate of $0.06 [1] Financial Performance Metrics - Practice Collections reached $739.90 million, exceeding the average estimate of $716.69 million from eight analysts [3] - Care Margin was reported at $101.40 million, slightly above the average estimate of $99.80 million based on seven analysts [3] - Platform Contribution amounted to $50.30 million, surpassing the average estimate of $47.22 million from seven analysts [3] - Implemented Providers totaled 4,642, compared to the average estimate of 4,607 from three analysts [3] - Attributed Lives stood at 1.25 million, exceeding the average estimate of 1.18 million from three analysts [3] Stock Performance - Privia Health's shares have returned +25.8% over the past month, significantly outperforming the Zacks S&P 500 composite's +3.2% change [4] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [4]

Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -50%. A quarter ago, it was expected that this physician practice management company would post earnings of $0.05 per share when it actually produced earnings of $0.03, delivering a surprise of -40%.Over the last fou ...

Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared Saving of $176.6 Million, +34.1% versus 2023Strong Adjusted EBITDA Growth and Free Cash Flow Generation ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter Performan ...

ARLINGTON, Va., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that its Accountable Care Organizations (ACOs) achieved shared savings of $176.6 million through the Medicare Shared Savings Program (MSSP) for the 2023 performance year, a 34.1% increase from 2022. The 10 ACOs (collectively, Privia Quality Network or PQN) managed over $2.3 billion in healthcare benchmark spend through approximately 2,850 providers delivering high-value, cost-efficient care to 194,786 ...

Privia Health (PRVA) reported $422.33 million in revenue for the quarter ended June 2024, representing a yearover-year increase of 2.2%. EPS of $0.03 for the same period compares to $0.06 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $412.43 million, representing a surprise of +2.40%. The company delivered an EPS surprise of -40.00%, with the consensus EPS estimate being $0.05. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- ...